American Well Corporation

NYSE:AMWL

Medical - Healthcare Information Services

Healthcare
$11.03 +2.82%

+$0.24 today

Market cap
$171.77M
Beta
1.70
P/E (TTM)
-1.6
EPS (TTM)
-$5.30
52W Low $3.71High $9.96

Volume 0.06M

Average 0.07M

AMWL Other Working Capital

Cash effect of changes in other operating assets and liabilities.

American Well CorporationNYSE: AMWL

Other Working Capital · Q1 FY2026 · quarter ended Mar 2026

Other working capital turns positive

Q1 FY2026 other working capital was $9.98M, compared with -$7.22M a year earlier. Trailing-twelve-month other working capital was -$19.57M. Over 3 fiscal years it compounded at +38.1% a year.

Context

  • Other working capital amounted to 14.7% of revenue in FY2025, up 9.6 pp from a year earlier.
  • Other working capital increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly other working capital holds near $9.98M or moves back toward the trailing-twelve-month quarterly average of -$4.89M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$9.98M+217.1% QoQ
Last fiscal yearDec 2025
-$36.77M-383.5% YoY
LTMMar 2026
-$19.57M+197.8% YoY
Other Working Capital past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+238.3%——
1 year-383.5%——
3-year CAGR+38.1%——
5-year CAGR——
10-year CAGR——

Other Working Capital history

USD · from the cash flow

Latest · FY2025
(36.77M) USD
Year-over-year change
-383.5%

Other Working Capital vs competitors

How AMWL compares with its peers on the latest reported figures

  • AMWL's LTM Mar 2026 other working capital of $19.57M is the 2nd largest of the 9 companies compared; the peer median is $495.53K.
  • Its year-over-year change of +197.8% is the 3rd highest of 9, against a peer median of +21.0%.
  • Other working capital amounts to 8.2% of revenue for AMWL, versus a peer median of 235.3%.
AMWL Competitors Peer median
Other Working Capital for AMWL and competitors
Company Period LTM YoY 3-year CAGR% of revenue
DTILPrecision BioSciences, Inc.LTM Mar 2026$23.36M -49.6%—51.8%
AMWLAmerican Well CorporationLTM Mar 2026$19.57M +197.8%+38.1%8.2%
CAMPCAMP4 Therapeutics CorporationLTM Mar 2026$16.48M +512.3%—418.8%
ATYRaTyr Pharma, Inc.LTM Mar 2026$9.35M +143.9%-15.8%4921.6%
IMUXImmunic, Inc.LTM Mar 2026$6.51M -4.9%-59.0%—
ALXOALX Oncology Holdings Inc.LTM Mar 2026$3.71M +541.3%——
GUTSFractyl Health, Inc. Common StockLTM Mar 2026$3.16M -184.1%——
BMEABiomea Fusion, Inc.LTM Mar 2026$743K -92.3%+8.4%—
EUDAEUDA Health Holdings LimitedLTM Jun 2026$248.05K +46.9%-57.8%2.0%
Peer median (excluding AMWL) $495.53K+21.0%-36.8%235.3%

Competitors are the stored peer set for AMWL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(176.78M)(272.07M)(675.16M)(208.14M)(95.7M)
Depreciation & Amortization16.09M26.17M31.92M33.43M33.96M
Deferred Income Tax(6.25M)(2.52M)(242K)(243K)(1.11M)
Stock-Based Compensation43.81M67.68M72.25M47.54M22.01M
Change in Working Capital(27.72M)(28.1M)(15.51M)(9.98M)(26.8M)
Accounts Receivables(512K)(8.14M)3.25M(25.01M)12.22M
Inventory1.6M(1.21M)2.09M1.9M1.17M
Accounts Payables5.55M(4.78M)(2.36M)159K(3.42M)
Other Working Capital(34.35M)(13.97M)(18.48M)12.97M(36.77M)
Other Non-Cash Items9.31M16.53M438.4M57.6M1.68M
Operating Cash Flow(141.54M)(192.32M)(148.34M)(127.34M)(65.95M)
Capital Expenditures(559K)(10.45M)(15.25M)(15.22M)(21K)
Acquisitions (Net)(159.07M)(1.96M)0(3.43M)18.32M
Purchases of Investments2.55M(499.22M)(389.99M)0(1M)
Sales of Investments100M500M389.99M00
Other Investing Activities(2.55M)0(18.88M)(15.1M)(196K)
Investing Cash Flow(59.63M)(11.63M)(19.17M)(18.65M)17.1M
Debt Repayment00000
Common Stock Issued0000844K
Common Stock Repurchased(15.04M)(360K)(586K)(3K)(4K)
Dividends Paid00000
Other Financing Activities20.79M(3.25M)2.73M1.38M0
Financing Cash Flow5.75M(3.61M)2.15M1.38M840K
Effect of Forex Changes(84K)(305K)(1.14M)887K2.02M
Net Change in Cash(195.5M)(207.87M)(166.51M)(143.72M)(45.99M)
Free Cash Flow(142.1M)(202.77M)(163.59M)(142.56M)(65.97M)

American Well Corporation

NYSE:AMWL

Intrinsic Alpha fair value

Locked

Current Price

$11.03

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.